Also categorized in PubMed:
Genome-wide analysis of HOXC9-induced neuronal differentiation of neuroblastoma cells.
x hide permanently

TIAM1 variants improve clinical outcome in neuroblastoma.

ncbi.nlm.nih.gov

TIAM1 variants improve clinical outcome in neuroblastoma.

Oncotarget. 2017 Apr 03;:

Authors: Sanmartín E, Yáñez Y, Fornés-Ferrer V, Zugaza JL, Cañete A, Castel V, Font de Mora J

Abstract Identification of tumor driver mutations is crucial for improving clinical outcome using a personalized approach to the treatment of cancer.

Mentions: Treatment ALK MYCN